(MedPage Today) — Most people surveyed wouldn’t be willing to take statins at their actual efficacy levels in primary prevention, according to a study with implications for shared decision-making.
When informed about potential adverse events…
Source link : https://www.medpagetoday.com/cardiology/dyslipidemia/119905
Author :
Publish date : 2026-02-17 17:23:00
Copyright for syndicated content belongs to the linked Source.
